Moreover, the highly significant correlation of fecal SCFA concentrations with age in controls, but not in patients, endorses the assumption that either MS or MS therapeutics affect the gut microbiome.
← all excerpts
Short-chain fatty acids and intestinal inflammation in multiple sclerosis: modulation of female susceptibility by microbial products?
2
—
—
The sentences
Yet, in RRMS this difference did not reach statistical significance (Table 3 , Fig. 4 ).